Telo Genomics Corp.
TELO.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.27% | 7.44% | 2.58% | 26.78% | -22.44% |
| Total Depreciation and Amortization | -42.50% | -37.50% | -12.33% | -6.41% | 1.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -278.38% | -116.16% | 45.86% |
| Change in Net Operating Assets | 150.43% | -35.64% | 402.21% | -69.06% | 211.85% |
| Cash from Operations | 15.43% | 7.00% | 14.58% | 14.01% | 2.51% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -109,900.00% | 99.48% | -- | -- | 100.00% |
| Cash from Financing | 1,661,700.00% | -100.02% | 2,777.25% | -- | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 500.03% | -546.48% | 117.14% | 10.68% | 3.22% |
